Core Laboratories Inc. (NYSE:CLB – Free Report) – Stock analysts at Zacks Research issued their Q1 2025 EPS estimates for Core Laboratories in a research note issued on Wednesday, March 26th. Zacks Research analyst T. Saha anticipates that the oil and gas company will post earnings per share of $0.15 for the quarter. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q3 2025 earnings at $0.24 EPS, Q4 2025 earnings at $0.24 EPS, FY2025 earnings at $0.83 EPS, Q2 2026 earnings at $0.24 EPS, Q3 2026 earnings at $0.28 EPS and FY2026 earnings at $1.04 EPS.
Core Laboratories (NYSE:CLB – Get Free Report) last announced its quarterly earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%.
Read Our Latest Analysis on CLB
Core Laboratories Trading Up 0.0 %
Shares of CLB stock opened at $15.00 on Monday. The stock’s 50-day moving average price is $16.23 and its 200-day moving average price is $18.08. Core Laboratories has a 12-month low of $12.95 and a 12-month high of $25.13. The stock has a market capitalization of $702.17 million, a price-to-earnings ratio of 22.72, a price-to-earnings-growth ratio of 0.99 and a beta of 2.38. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in CLB. The Manufacturers Life Insurance Company lifted its stake in shares of Core Laboratories by 19.1% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 21,511 shares of the oil and gas company’s stock valued at $399,000 after purchasing an additional 3,457 shares during the last quarter. Quantbot Technologies LP purchased a new stake in Core Laboratories during the 3rd quarter valued at $211,000. FMR LLC lifted its position in Core Laboratories by 182.9% in the third quarter. FMR LLC now owns 17,057 shares of the oil and gas company’s stock worth $316,000 after buying an additional 11,028 shares during the last quarter. Captrust Financial Advisors purchased a new position in Core Laboratories during the third quarter worth $997,000. Finally, State Street Corp increased its position in Core Laboratories by 2.9% during the third quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company’s stock valued at $36,597,000 after acquiring an additional 56,187 shares during the last quarter. Hedge funds and other institutional investors own 97.81% of the company’s stock.
Core Laboratories Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Monday, February 10th were issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.27%. The ex-dividend date of this dividend was Monday, February 10th. Core Laboratories’s payout ratio is 6.06%.
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Read More
- Five stocks we like better than Core Laboratories
- Using the MarketBeat Dividend Yield Calculator
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- How to find penny stocks to invest and tradeĀ
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- What is a penny stock? A comprehensive guide
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.